109 related articles for article (PubMed ID: 2049316)
1. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Report of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Santini G; Coser P; Chisesi T; Porcellini A; Sertoli R; Contu A; Vinante O; Congiu AM; Carella AM; D'Amico T
Ann Oncol; 1991 Feb; 2 Suppl 2():181-5. PubMed ID: 2049316
[TBL] [Abstract][Full Text] [Related]
2. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG).
Santini G; Coser P; Chisesi T; Porcellini A; Sertoli R; Contu A; Congiu AM; Manna A; Rossi E; Scarpati D
Bone Marrow Transplant; 1989 Jul; 4(4):399-404. PubMed ID: 2673460
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG.
Santini G; Congiu AM; Coser P; Chisesi T; Porcellini A; Sertoli R; Contu A; Vinante O; Pierluigi D; Vitale V
Leukemia; 1991; 5 Suppl 1():42-5. PubMed ID: 1890865
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission.
Nademanee A; Molina A; Fung H; Stein A; Parker P; Planas I; O'Donnell MR; Snyder DS; Kashyap A; Spielberger R; Bhatia R; Krishnan A; Sniecinski I; Vora N; Slovak M; Dagis A; Niland JC; Forman SJ
Biol Blood Marrow Transplant; 1999; 5(5):292-8. PubMed ID: 10534059
[TBL] [Abstract][Full Text] [Related]
5. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
Nademanee A; Molina A; Dagis A; Snyder DS; O'Donnell MR; Parker P; Stein A; Smith E; Planas I; Kashyap A; Spielberger R; Fung H; Krishnan A; Bhatia R; Wong KK; Somlo G; Margolin K; Chow W; Sniecinski I; Vora N; Slovak M; Niland JC; Forman SJ
Clin Lymphoma; 2000 Jun; 1(1):46-54. PubMed ID: 11707813
[TBL] [Abstract][Full Text] [Related]
6. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
7. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.
Snyder DS; Findley DO; Forman SJ; Nademanee AP; O'Donnell MR; Schmidt GM; Bierman PJ; Fahey JL; Krance RA; Sniecinski IJ
Blut; 1988 Jul; 57(1):7-13. PubMed ID: 3291991
[TBL] [Abstract][Full Text] [Related]
8. High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation.
Sweetenham JW; Proctor SJ; Blaise D; De Laurenzi A; Pearce R; Taghipour G; Goldstone AH; Laurenzi A [corrected to De Laurenzi A]
Ann Oncol; 1994; 5 Suppl 2():155-9. PubMed ID: 7515646
[TBL] [Abstract][Full Text] [Related]
9. Autologous bone marrow transplantation with marrow decontaminated by immunotoxin T 101 in the treatment of leukemia and lymphoma: first clinical observations.
Gorin NC; Douay L; Laporte JP; Lopez M; Zittoun R; Rio B; David R; Stachowiak J; Jansen J; Cazellas P
Cancer Treat Rep; 1985 Sep; 69(9):953-9. PubMed ID: 3896482
[TBL] [Abstract][Full Text] [Related]
10. Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia.
Bernasconi C; Brusamolino E; Lazzarino M; Morra E; Pagnucco G; Orlandi E
Ann Oncol; 1990; 1(2):141-6. PubMed ID: 2078494
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission.
Milpied N; Ifrah N; Kuentz M; Maraninchi D; Colombat P; Blaise D; Harousseau JL
Br J Haematol; 1989 Sep; 73(1):82-7. PubMed ID: 2803982
[TBL] [Abstract][Full Text] [Related]
12. Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia.
Straus DJ; Wong GY; Liu J; Oppenberg J; Filippa DA; Gold JW; Offit K; Clarkson BD
Am J Med; 1991 Mar; 90(3):328-37. PubMed ID: 2003515
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
[TBL] [Abstract][Full Text] [Related]
14. Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies.
Cole CH; Pritchard S; Rogers PC; Davis JE; Phillips G; Chan KW
Med Pediatr Oncol; 1994; 23(6):464-9. PubMed ID: 7935171
[TBL] [Abstract][Full Text] [Related]
15. [High dose chemoradiotherapy and autologous bone marrow transplantation (ABMT) as a first line therapy to treat advanced adult high-grade malignant T-cell non-Hodgkin's lymphoma--a pilot clinical study].
Wu GQ
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):47-51. PubMed ID: 7687533
[TBL] [Abstract][Full Text] [Related]
16. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.
Blume KG; Forman SJ; Snyder DS; Nademanee AP; O'Donnell MR; Fahey JL; Krance RA; Sniecinski IJ; Stock AD; Findley DO
Transplantation; 1987 Mar; 43(3):389-92. PubMed ID: 3547796
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Sullivan MP; Boyett J; Pullen J; Crist W; Doering EJ; Trueworthy R; Hvizdala E; Ruymann F; Steuber CP
Cancer; 1985 Jan; 55(2):323-36. PubMed ID: 3880656
[TBL] [Abstract][Full Text] [Related]
19. Childhood non-Hodgkin's lymphoma and "leukemia-lymphoma syndrome": long-term results with the modified LSA2-L2 protocol.
Vecchi V; Serra L; Pession A; Rosito P; Paolucci P; Burnelli R; Vivarelli F; Mancini AF; Paolucci G
Pediatr Hematol Oncol; 1986; 3(3):217-28. PubMed ID: 3153234
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]